Multiple Sclerosis TopicsShow More
The FDA recently approved two new drugs that give people with active secondary progressive multiple sclerosis more treatment choices than ever.
Multiple sclerosis requires you to learn large amounts of information. During pregnancy, one concern is your MS medication.
The new medications, siponimod (Mayzent, Novartis) and cladribine (Mavenclad, EMD Serono), bring treatment options to active secondary progressive multiple sclerosis (SPMS). Most treatments approved for MS are for relapsing, rather than progressive, forms of the disease.
Multiple sclerosis treatment is one of the fastest moving areas of medicine.
Patients living with multiple sclerosis (MS) in the US may try these disease-modifying therapies (DMTs) to slow down the long-term progression of the disease.
Several medications used for MS are injectable drugs — aka, shots. We’ve been running from shots since we were kids, but they don’t have to hurt as badly as we remember. Here are some simple tips to minimize the pain, while maximizing the treatment.
Cleveland Clinic researchers led phase 2 clinical trials for an oral medication, ibudilast, that slowed brain shrinkage in people with progressive multiple sclerosis by 48 percent.
Learn about the four main infusion therapies available for MS today – the course of treatment and what you need to know on infusion day.
When do you switch your MS medication? How do you measure your treatment’s effectiveness? A woman with MS shares her experience and advice. Tune in to know when to make a change.
A new meta-analysis study reinforces the importance of early treatment upon MS diagnosis to prevent disability.